http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3403657-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9eae8c9f91cf4fde470b64db683dc42d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
filingDate 2006-10-06^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_052283a19de26661db331c33e4c3054b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b8f32bfb81f01e5af9cf4c4099acdac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_171fada2ad53643e66afabfa10e14788
publicationDate 2018-11-21^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3403657-A1
titleOfInvention Use of oligouronates for treating mucus hyperviscosity
abstract The invention provides oligouronates, especially oligoguluronic acids, for use in medicine. In particular, oligouronates for use in the reduction of mucosal hyperviscosity in the digestive tract are provided. Such oligouronates may in particular be used in the treatment of constipation associated with mucosal hyperviscosity in the gut.
priorityDate 2005-10-06^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09208472-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003013678-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8809794-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396296
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7059415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394721

Showing number of triples: 1 to 48 of 48.